The prostatic imperative and the social relations of medical technology

International Journal of Technology Assessment in Health Care

Volumn 13, Issue 4, 1997, Pages 602-612

  Willis, Evan ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER SCREENING; CLINICAL PATHWAY; CLINICAL TRIAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; MASS SCREENING; PROSTATE CANCER; REVIEW; SCREENING TEST; SOCIETY; SOCIOLOGY;

EID: 0031471248     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300010072     Document Type: Review

References (29)

1. The Age, (Melbourne newspaper), November 28, 1996.
2. Australian Health Technology Advisory Committee. Prostate cancer screening. Canberra: Australian Government Publishing Service, National health and Medical Research Council, 1996.
3. Borland, R., Donaghue, N., & Hill, D. Illnesses that Australians most feared in 1986 and 1993. Australian Journal of Public Health 1994, 18, 366-69.
4. Broom, D. Damned if we do: Contradictions in women's health care. Sydney: Allen & Unwin, 1991.
5. Burton, T. Blood test for prostate cancer is raising issues of reliability, drug-industry role. Wall Street Journal, February 16, 1993.
6. Denis, L. J. To screen or not to screen? Prostate 1992, (suppl. 4), 63-70.
7. Dickson, D. Alternative technology and the politics of technological change. Glasgow: Fontana, 1974.
8. Feightner, J. Screening for prostate cancer. In The Canadian Task Force on Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, 1994.
9. Fletcher, R. Prostate cancer screening and men's health. Australian Journal of Public Health, 1994, 18, 449-51.
10. Gerber, P. How far should we investigate and treat prostate cancer: A lawyer's perspective (letter). Medical Journal of Australia, 1994, 160, 523.
11. Gohagan, J. K., Prorok, P. C., Kramer, B. S., & Cornett, J. E. The prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. Cancer, 1995, 75, 1869-73.
12. Green, C. J., Hadorn, D., Bassett, A., & Kazanjian, A. Prostate specific antigen in the early detection of prostate cancer. British Columbia Office of Health Technology Assessment Discussion Paper Series. Vancouver: BCHOTA 93:6D, 1993.
13. Kolata, G. How demand surged for prostate test. New York Times, September 29, 1993, C12.
14. LaTour, B., & Woolgar, S. Laboratory life: The social construction of scientific facts. Beverly Hills: Sage, 1979.
15. McKinlay, J. The business of good doctoring or doctoring as good business: Reflections on Freidson's view of the medical game. International Journal of Health Services, 1977, 7, 459-88.
16. McKinlay, J. From 'promising report' to 'standard procedure': Seven stages in the career of medical innovation. Milbank Memorial Fund Quarterly, 1981, 59, 374-411.
17. Norlen, B. J. Swedish randomized trial of radical prostatectomy versus watchful waiting. Canadian Journal of Oncology, 1994, 4(supp. 1), 38-40.
18. Payer, L. Medicine & culture: Varieties of treatment in the United States, England, West Germany and France. New York: henry Holt & Co. 1988.
19. Schroder, F. H. The European screening study for prostate cancer. Canadian Journal of Oncology, 1994, 4(suppl. 1), 102-05.
20. Tesh, S. Hidden arguments: Political ideology and disease preventioN, New Brunswick, NJ: Rutgers University Press, 1988.
21. The prostate: an owner's manual. Washington Post, May 23, 1995, special issue.
22. Wasson, J. Prostate cancer: Facts and fears. In Proceedings from National Men's Health Conference, Melbourne. Canberra: Australian Government Publishing Service, 1996, 49-53.
23. Wasson, J. H., Cushman, C. C., Bruskewitz, R. C., et al. A structured literature review of treatment for localised prostate cancer. Archives of Family Medicine, 1993, 2, 487-93.
24. Weiss, R., & Thier, S. HIV testing is the answer: What's the question. New England Journal of Medicine. 1988, 319, 1010-12.
25. Whitmore, W. F., Jr. Overview: Historical and contemporary. National Cancer Institute Monographs, 1988, 7, 7-11.
26. Willis, E. Illness and social relations. Sydney: Alien & Unwin, 1994.
27. Willis, E., & Daly, J. The social relations of medical technologies: The case of sleep disorder centres. In C. Waddell & A. Petersen (eds.), Just health. Melbourne: Churchill Livingstone, 1993.
28. Wilson, J. M. G., & Jungner, G. Principles and practice of screening for disease. Geneva: WHO (Public Health paper), 1968.
29. Wilt, T. J., & Brawer, M. K. The prostate intervention versus observation trial: A randomised control trial comparing radical prostatectomy versus expectant management for the treatment of clinically localised prostate cancer. Cancer, 1995, 75, 1963-68.